CG ONCOLOGY INC (CGON) Stock Analyst Ratings
NASDAQ:CGON • US1569441009
56.99 USD
-1.35 (-2.31%)
At close: Feb 25, 2026
56.9 USD
-0.09 (-0.16%)
Pre-Market: 2/26/2026, 4:46:46 AM
ChartMill assigns a Buy % Consensus number of 84% to CGON. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 82.62. This target is 44.97% above the current price.
- CGON was analyzed by 21 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CGON.
- In the previous month the buy percentage consensus was at a similar level.
- CGON was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-10 | Truist Securities | Maintains | Buy -> Buy |
| 2026-01-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-01-16 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-12 | Truist Securities | Maintains | Buy -> Buy |
| 2025-12-11 | Wedbush | Initiate | Outperform |
| 2025-11-24 | Truist Securities | Initiate | Buy |
| 2025-11-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-08 | Guggenheim | Initiate | Buy |
| 2025-09-26 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-09-17 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-08 | Jones Trading | Initiate | Buy |
| 2025-09-08 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-09-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-19 | Piper Sandler | Initiate | Overweight |
| 2025-07-16 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-06-17 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-19 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-02 | JP Morgan | Initiate | Overweight |
| 2025-04-29 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-28 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-04-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-16 | ScotiaBank | Initiate | Sector Perform |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-07 | TD Cowen | Initiate | Buy |
| 2024-12-06 | RBC Capital | Reiterate | Outperform -> Outperform |
CG ONCOLOGY INC / CGON FAQ
What do analysts expect the price target to be for CG ONCOLOGY INC (CGON)?
21 analysts have analysed CGON and the average price target is 82.62 USD. This implies a price increase of 44.97% is expected in the next year compared to the current price of 56.99.
Can you provide the consensus rating for CG ONCOLOGY INC stock?
The consensus rating for CG ONCOLOGY INC (CGON) is 83.8095 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed CG ONCOLOGY INC (CGON)?
The number of analysts covering CG ONCOLOGY INC (CGON) is 21.